Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Public ClinicalTrials.gov record NCT03941184. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Determining the Association Between Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This case control study aims to determine whether spontaneous coronary artery dissection (SCAD) is associated with autoimmune diseases and to update the incidence of SCAD in a population-based cohort.
Study identification
- NCT ID
- NCT03941184
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 114 participants
Conditions and interventions
Conditions
- SCAD
- Addison Disease
- Ankylosing Spondylitis
- Antiphospholipid Antibody Syndrome
- Celiac Disease
- Crohn Disease
- Dermatomyositis
- Polymyositis
- Guillain-Barre Syndrome
- Hepatitis, Autoimmune
- Graves Disease
- Hashimoto Thyroiditis
- Multiple Sclerosis
- Myasthenia Gravis
- Pernicious Anemia
- Polymyalgia Rheumatica
- Primary Biliary Cirrhosis
- Psoriasis
- Rheumatoid Arthritis
- Systemic Sclerosis
- Sjögren Syndrome
- Systemic Lupus Erythematosus
- Takayasu Arteritis
- Type 1 Diabetes Mellitus
- Ulcerative Colitis
- Uveitis
- Vasculitis
- Vitiligo
- Raynaud
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years to 110 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 1994
- Primary completion
- Nov 9, 2020
- Completion
- Nov 9, 2020
- Last update posted
- Nov 22, 2020
1995 – 2020
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03941184, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2020 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03941184 live on ClinicalTrials.gov.